http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2322964-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H39-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067 |
| filingDate | 2006-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40eea1e0f13c277df7cc96583c6465e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93dad639f9fefa167033f4a2f98c16ee |
| publicationDate | 2008-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2322964-C1 |
| titleOfInvention | Method for treating bronchial obstructive syndrome in children suffering from acute respiratory diseases |
| abstract | FIELD: medicine. n SUBSTANCE: method involves introducing bacterial immunomodulator IRS-19 as inhalation. Massage with needle roller is carried out daily along meridian V 2-3 min long in paravertebral mode. Then, balls application is administered by means of hypoallergenic plaster for carrying out tsubo-therapy on corporal points of Gi 4, E 36, VC 22, VG 14, V12, V13,P1 auricular points of 29, 31, 55, 60, 101. The points are periodically massaged in daytime every 1.5-2 h with 1-2 min long treatment with each ball. Transcutaneous permanent magnetic field treatment and low intensity laser treatment is applied with 25-30 mW power, wavelength of 0.85-0.95 mcm pulse succession frequency of 80 Hz. Transducer is moved over 0.5 cm far from skin surface. Thymus area, suprarenal gland and main bronchi projections are treated at the level of Th3-Th6 of ulnar vascular fascicle 1 min per each field. The total treatment course is 8-10 days long. n EFFECT: reduced risk of relapses; low drug loading intensity. n 1 tbl |
| priorityDate | 2006-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.